Robert Whelan Jr. - May 23, 2022 Form 4 Insider Report for Aspen Technology, Inc. (AZPN)

Role
Director
Signature
/s/ F.G. Hammond, attorney-in-fact for Mr. Whelan
Stock symbol
AZPN
Transactions as of
May 23, 2022
Transactions value $
$0
Form type
4
Date filed
5/25/2022, 07:03 PM
Previous filing
May 17, 2022
Next filing
Sep 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AZPN Director Stock Option (Right to Buy) Award +3.11K 3.11K May 23, 2022 Common Stock 3.11K $36.53 Direct F1, F2
transaction AZPN Director Stock Option (Right to Buy) Award +2.33K 2.33K May 23, 2022 Common Stock 2.33K $48.76 Direct F1, F3
transaction AZPN Director Stock Option (Right to Buy) Award +2.95K 2.95K May 23, 2022 Common Stock 2.95K $49.81 Direct F1, F4
transaction AZPN Director Stock Option (Right to Buy) Award +3.27K 3.27K May 23, 2022 Common Stock 3.27K $51.03 Direct F1, F5
transaction AZPN Director Stock Option (Right to Buy) Award +2.52K 2.52K May 23, 2022 Common Stock 2.52K $70.99 Direct F1, F6
transaction AZPN Director Stock Option (Right to Buy) Award +1.43K 1.43K May 23, 2022 Common Stock 1.43K $129.48 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents equity awards granted by Aspen Technology, Inc. (which subsequently changed its name to "AspenTech Corporation", "Former AspenTech") that have been converted into equity awards of Emersub CX, Inc. (which subsequently changed its name to "Aspen Technology Inc.", the "Issuer") pursuant to the terms of the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Former AspenTech, the Issuer and certain other parties thereto (the "Transaction Agreement"), pursuant to which Former AspenTech merged with a wholly owned subsidiary of the Issuer and became a wholly owned subsidiary of the Issuer (the "Transaction"). The Transaction closed on May 16, 2022. Pursuant to the terms of the Transaction Agreement, the number of equity awards reported herein were determined on May 23, 2022, based on the five-day volume weighted average price of the Issuer's common stock following the closing of the Transaction.
F2 The option granted at the exercise price of $36.53was fully vested on the date of grant.
F3 The option granted at the exercise price of $48.78was fully vested on the date of grant.
F4 The option granted at the exercise price of $49.81 was fully vested on the date of grant.
F5 The option granted at the exercise price of $51.03 was fully vested on the date of grant.
F6 The option granted at the exercise price of $70.99 was fully vested on the date of grant.
F7 The option granted at the exercise price of $129.48 was fully vested on the date of grant.